Sector News

Categories

Borderless Insights

Image
Negotiating Terms with a New Employer
Image
Beyond Flowers and Platitudes: Reclaiming the Essence of International Women’s Day
Image
Visionary or ‘Stuck-in-the-Mud’? Where are you on Workplace Flexibility?

Drugmaker GSK to steer Asian business from new Singapore HQ

March 11, 2015
Life sciences
(Reuters) – Drugmaker GlaxoSmithKline will establish a new headquarters for Asia in Singapore to make quicker decisions for the region, a move that follows a recent rocky ride in China due to a damaging bribery scandal.
 
The British-based group said it expects its pharmaceutical, consumer healthcare and vaccine businesses to grow significantly faster in Asia than in the rest of the world.
 
“While we expect it to be a bit slower going forward than it was five years ago, we still think it’s going to be a very vibrant growth area,” Chief Executive Andrew Witty told reporters.
 
Witty has made emerging markets a priority for GSK since taking over in 2008.
 
GSK has over 700 office-based employees in Singapore and expects an additional 100 roles to move into the country as the headquarters nears completion. Construction is expected to be finished by the end of 2016.
 
Asia business decisions are currently mainly handled out of London.
 
Last year, the drugmaker was fined 3 billion yuan ($479 million) in China following allegations in 2013 it funnelled funds to travel agencies to facilitate bribes to doctors and officials. The high-profile case hit GSK’s drug sales in the country.
 
It is dismissing 110 employees in China for misconduct, people familiar with the matter said this month.
 
“I don’t have an expectation that there will be more people leaving, but equally if we found somebody else who did something wrong then they would go through the process and whatever would happen would happen,” Witty said.
 
GSK’s move follows similar ones by other global companies, including automaker General Motors Co, which moved its international operations headquarters to the city-state last year.
 
Companies are lured to Singapore by its competitive tax rates, use of the English language, skilled workforce and high standards of living. (Reporting by Aradhana Aravindan and Ben Hirschler; Editing by Tom Heneghan and Edwina Gibbs)

comments closed

Related News

April 26, 2024

Former Bristol Myers CEO tapped as Novartis’ next board chair

Life sciences

Giovanni Caforio, the former CEO of Bristol Myers Squibb, is set to become the next board chairman of Novartis, which on Tuesday proposed the pharmaceutical industry veteran as its pick to replace Joerg Reinhardt in the role next year. Reinhardt has served as Novartis’ chair since 2013 and plans to retire when his 12-year term ends in 2025.

Read more
April 26, 2024

GE HealthCare launches voice-activated, AI-powered ultrasound machines for women’s health

Life sciences

GE HealthCare has raised the curtain on two ultrasound systems equipped with artificial intelligence programs designed to assist in diagnosing conditions in women’s health, including obstetric exams. The Voluson Signature 20 and 18 imaging systems include AI tools capable of automatically identifying and annotating measurements of fetal anatomy.

Read more
April 26, 2024

Scientists reveal new method that could reduce waste from drug manufacturing

Life sciences

Scientists from the University of Edinburgh’s School of Chemistry have revealed a new sustainable method of manufacturing complex molecules that could reduce waste produced during drug production. The method published in Nature Chemistry could help to prevent severe side effects caused by drugs that can exist as enantiomers.

Read more
More news

How can we help you?

We're easy to reach